Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Lazarus

Showing results (411-420 of 434) with videos related to

Pageof 44
Sort By:
Hepatology Communications|February 5, 2024
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statementHannes Hagström, Leon A Adams, Alina M Allen, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission updateGraham S Cooke, Barnaby Flower, Evan Cunningham, et al.
Nature Reviews. Gastroenterology & Hepatology|October 28, 2021
Advancing the global public health agenda for NAFLD: a consensus statementJeffrey V Lazarus, Henry E Mark, Quentin M Anstee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 5, 2022
Securing wider EU commitment to the elimination of hepatitis C virusHeiner Wedemeyer, Tammo L Tergast, Jeffrey V Lazarus, et al.
The Lancet. Gastroenterology & Hepatology|October 8, 2017
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in EuropeAlison D Marshall, Evan B Cunningham, Stine Nielsen, et al.
The Lancet Regional Health. Europe|June 10, 2026
Assessing Europe's policy readiness to confront the MASLD/MASH public health threatJeffrey V Lazarus, Trenton M White, Leire Agirre-Garrido, et al.
The Lancet. Gastroenterology & Hepatology|April 17, 2022
The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the AmericasLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.
Nature Medicine|June 5, 2025
The People-First Liver CharterJeffrey V Lazarus, Dana Ivancovsky Wajcman, Silvana Pannain, et al.
Nature|November 4, 2022
A multinational Delphi consensus to end the COVID-19 public health threatJeffrey V Lazarus, Diana Romero, Christopher J Kopka, et al.
Lancet (London, England)|September 17, 2022
The Lancet Commission on lessons for the future from the COVID-19 pandemicJeffrey D Sachs, Salim S Abdool Karim, Lara Aknin, et al.
Pageof 44

Showing results (411-420 of 434) with videos related to

Sort By:
Pageof 44
Hepatology Communications|February 5, 2024
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statementHannes Hagström, Leon A Adams, Alina M Allen, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission updateGraham S Cooke, Barnaby Flower, Evan Cunningham, et al.
Nature Reviews. Gastroenterology & Hepatology|October 28, 2021
Advancing the global public health agenda for NAFLD: a consensus statementJeffrey V Lazarus, Henry E Mark, Quentin M Anstee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 5, 2022
Securing wider EU commitment to the elimination of hepatitis C virusHeiner Wedemeyer, Tammo L Tergast, Jeffrey V Lazarus, et al.
The Lancet. Gastroenterology & Hepatology|October 8, 2017
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in EuropeAlison D Marshall, Evan B Cunningham, Stine Nielsen, et al.
The Lancet Regional Health. Europe|June 10, 2026
Assessing Europe's policy readiness to confront the MASLD/MASH public health threatJeffrey V Lazarus, Trenton M White, Leire Agirre-Garrido, et al.
The Lancet. Gastroenterology & Hepatology|April 17, 2022
The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the AmericasLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.
Nature Medicine|June 5, 2025
The People-First Liver CharterJeffrey V Lazarus, Dana Ivancovsky Wajcman, Silvana Pannain, et al.
Nature|November 4, 2022
A multinational Delphi consensus to end the COVID-19 public health threatJeffrey V Lazarus, Diana Romero, Christopher J Kopka, et al.
Lancet (London, England)|September 17, 2022
The Lancet Commission on lessons for the future from the COVID-19 pandemicJeffrey D Sachs, Salim S Abdool Karim, Lara Aknin, et al.
Pageof 44